Gut microbiota alterations in patients with non‐small‐cell lung cancer undergoing chemoradiotherapy
Hanne Marte Nymoen, Zhi Zhao, Henrik Horndalsveen, Maria Moksnes Bjaanæs et autres
0 citationsMolecular Oncology
Henrik Horndalsveen
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
19Publications signalées
66Citations signalées
2Affiliations récentes
Institutions déclarées
Domaines associés
Cancer Immunotherapy and BiomarkersLung Cancer Treatments and MutationsLung Cancer Diagnosis and TreatmentCancer Genomics and DiagnosticsGut microbiota and health
Publications récentes
ctDNA-Based MRD Detection in Stage III NSCLC Treated With Chemoradiotherapy and Durvalumab
Henrik Horndalsveen, Vilde Drageset Haakensen, Tesfaye Madebo, Bjørn Henning Grønberg et autres
0 citationsJournal of Thoracic Oncology
How does pulmonary function impact QoL in patients with locally advanced NSCLC treated with chemoradiotherapy and durvalumab?
Frigg Å. Sommervoll, Henrik Horndalsveen, Dag Einar Sommervoll, Jussi Koivonen et autres
0 citationsActa Oncologica
Upfront treatment with osimertinib in lung cancer patients with and without active brain metastases, and the role of ctDNA as a biomarker; a phase II clinical trial (the FIOL study)
Elin Marie Stensland, Simone Stensgaard, Inger Johanne Z. Eide, Yngvar Nilssen et autres
0 citationsLung Cancer
Blood-based tumor mutational burden as a biomarker in unresectable non-small cell lung cancer treated with chemoradiotherapy and durvalumab
Henrik Horndalsveen, Vilde Drageset Haakensen, Tesfaye Madebo, Bjørn Henning Grønberg et autres
2 citationsFrontiers in Oncology
1819P ctDNA-based detection of minimal residual disease in patients with unresectable NSCLC treated with chemoradiotherapy and durvalumab
Henrik Horndalsveen, Vilde Drageset Haakensen, Tesfaye Madebo, Bjørn Henning Grønberg et autres
0 citationsAnnals of Oncology
204eP Gut microbiota changes in patients with non-small cell lung cancer undergoing chemoradiotherapy
H.M. Nymoen, Zhiyao Zhao, Henrik Horndalsveen, Tine Norman Alver et autres
0 citationsAnnals of Oncology
ctDNA-based MRD detection in unresectable NSCLC undergoing curatively intended chemoradiotherapy and durvalumab.
Henrik Horndalsveen, Vilde Drageset Haakensen, Tesfaye Madebo, Bjørn Henning Grønberg et autres
8 citationsJournal of Clinical Oncology
Serum cytokines as a biomarker for immune checkpoint inhibitor toxicity in patients with pleural mesothelioma
S.J. Farooqi, Zhi Zhao, Åsa Kristina Öjlert, Solfrid Thunold et autres
9 citationsFrontiers in Immunology
Thoracic radiation in combination with erlotinib—results from a phase 2 randomized trial
H.M. Nymoen, Tine Norman Alver, Henrik Horndalsveen, H. Eide et autres
0 citationsFrontiers in Oncology
Factors associated with failure to start consolidation durvalumab after definitive chemoradiation for locally advanced NSCLC
Christian Wilhelm Langberg, Henrik Horndalsveen, Åslaug Helland, Vilde Drageset Haakensen
5 citationsFrontiers in Oncology
Sjekkpunkthemmerindusert myokarditt
Geeta Gulati, Kristin Holm Tjessem, Henrik Horndalsveen, Sigrun Halvorsen et autres
1 citationTidsskrift for Den norske legeforening
BNTIC News n’est pas le producteur de ces données. Métadonnées interrogées à la demande auprès de OpenAlex (CC0). Sources et limites.